查詢結果分析
來源資料
相關文獻
- Estimation of the Miscoded Suicide Rate: A Cross-cultural Comparison between Mexico and Ecuador
- Emergency Medical Resource Use in Taipei City
- 腸炎沙門氏桿菌污染之三明治引起的集體食品中毒事件
- 一九九八墨西哥投資環境回顧
- Mapping Indicators of Land Degradation Induced by Bush Invasion in Jornada Southern New Mexico Using Landsat TM Imagery
- 機動車事故傷害發生地、死亡地與戶籍地關係之初探:花東經驗
- Pharmacoepidemiology藥物流行病學--clinical pharmacology(臨床藥理學)和epidemiology(流行病學)結合而產生的一門新學科
- 胃幽門螺旋桿菌的微生物學與流行病學
- 宜蘭縣南澳鄉與南投縣仁愛鄉泰雅族原住民和當地動物弓蟲抗體之血清流行病學研究
- 臺灣新竹地區C型肝炎病毒感染之血清流行病學研究
頁籤選單縮合
題 名 | Estimation of the Miscoded Suicide Rate: A Cross-cultural Comparison between Mexico and Ecuador=錯誤登錄的自殺率之估計:墨西哥與厄瓜多爾之比較 |
---|---|
作 者 | 胡海國; | 書刊名 | 臺灣精神醫學 |
卷 期 | 13:4 1999.12[民88.12] |
頁 次 | 頁30-44 |
分類號 | 412.41 |
關鍵詞 | 錯誤登錄; 自殺率; 墨西哥; 厄瓜多爾; 流行病學; Epidemiology; Suicide; Under-reported; |
語 文 | 英文(English) |
中文摘要 | Objective: A formula to estimate the magnitude of miscoding of suicide cases was developed and then empirically evaluated in a cross-cultural setting. Methods: An indirect method based on the developed formula was used to estimate the magnitude of under-reporting of suicide in Mexico and Ecuador during a five-year-period. Results: In the quinquennium analyzed, the under-reported suicide rate was significantly higher in Mexico (41.95%) than in Ecuador (3.57%). In Mexico the under-reported suicide percentage was higher in female (56.23%) than in male (49.07%). In both countries the percentage of under-reported cases in men was higher when the deaths involved passive or soft methods of self-destruction in comparison with the more active or harder methods that were utilized in the cases of women. Conclusion: The results of this study demonstrate that with the developed formula is possible to estimate the magnitude of the unknown number of suicides. Its incorporation into the cross-cultural research framework may enable better control over type I and II errors. |
英文摘要 | 目的:Fluvoxamine加入clozaphine血中濃度顯著提高。本文探討長期使用 clozapine之精神分裂症患者,將clozaphine減半,加入fluvoxamine對精神病症狀、血液 、及其他副作用之影響。方法:36位長期使用clozapine平均26.1個月之精神分裂症患者 (男22位,平均36.6歲,使用clozapine每天368mg;女14位,平均30.4歲,使用 clozaphine每天332mg)參與研究。給藥方式為clozaphine減半,加上fluvoxamine每日25 mg使用3天,50mg使用39天。結果:以實施前後比較80.6%病患精神病症狀改善,14%維持不 變,5.6%變差。BPRS由26.8降至21.2,在統計上有意義(p=0.007),正、負性症狀都有改 善(p=0.001,p=0.001),整體臨床印象及病患自評有52.8%症狀改善,38.9%維持不變, 8.3%變差。生化血液無影響。副作用(總分76)由1.63升為2.33在統計上有差異(p=0.01) ,以嗜睡、疲倦、流口水、便祕、頭暈居多。對clozapine難治17位病患,BPRS由平均36.7 降至27.2,16位症狀亦有明顯改善。結論:將clozapine減半,加入fluvoxamine每日50mg 可改善精神分裂症正負性症狀,對血液、生化無影響,副作用稍微增加。只有5.6-8.3%精 神病症狀變差,而加入抗焦慮劑或增加每日50mg clozapine則可改善。對clozapine 難治 病患亦有明顯改善。 |
本系統中英文摘要資訊取自各篇刊載內容。